Publication: Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient.
No Thumbnail Available
Identifiers
Date
2017
Authors
Romero-Laorden, N
Piñeiro-Yañez, E
Gutierrez-Pecharroman, A
Pacheco, M I
Calvo, E
Al-Shahrour, F
Castro, E
Olmos, D
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Aged
BRCA2 Protein
Benzimidazoles
Genes, BRCA2
Germ-Line Mutation
Humans
Loss of Heterozygosity
Male
Poly(ADP-ribose) Polymerase Inhibitors
Prostatic Neoplasms, Castration-Resistant
BRCA2 Protein
Benzimidazoles
Genes, BRCA2
Germ-Line Mutation
Humans
Loss of Heterozygosity
Male
Poly(ADP-ribose) Polymerase Inhibitors
Prostatic Neoplasms, Castration-Resistant